Hopp til innhold

Akuttmedisin

Fremme hemostase

Antifibrinolytika

Alternatives to allogeneic platelet transfusion. (åpner nytt vindu)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Kilde‎: Br J Haematol 2016;175(3):381-92.

Arkiv‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (åpner nytt vindu)

Antifibrinolytic drugs for acute traumatic injury. (åpner nytt vindu)

Ker K, Roberts I, Shakur H, Coats TJ.

Kilde‎: Cochrane Database Syst Rev 2015;(5):CD004896.

Arkiv‎: PubMed 25956410

DOI‎: 10.1002/14651858.CD004896.pub4

https://www.ncbi.nlm.nih.gov/pubmed/25956410 (åpner nytt vindu)

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (åpner nytt vindu)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Kilde‎: JAMA Surg 2013;148(3):218-25.

Arkiv‎: PubMed 23670117

DOI‎: 10.1001/jamasurg.2013.764

https://www.ncbi.nlm.nih.gov/pubmed/23670117 (åpner nytt vindu)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (åpner nytt vindu)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Kilde‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Arkiv‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (åpner nytt vindu)

Rekombinant aktivert faktor VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (åpner nytt vindu)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Kilde‎: Transfusion 2009;49 Suppl 5:240S-7S.

Arkiv‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (åpner nytt vindu)

Koagulasjonsfaktorkonsentrater

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (åpner nytt vindu)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Kilde‎: Injury 2013;44(2):209-16.

Arkiv‎: PubMed 23000050

DOI‎: 10.1016/j.injury.2012.08.047

https://www.ncbi.nlm.nih.gov/pubmed/23000050 (åpner nytt vindu)

Desmopressin

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (åpner nytt vindu)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Kilde‎: J Trauma Acute Care Surg 2020;88(1):80-6.

Arkiv‎: PubMed 31688782

DOI‎: 10.1097/TA.0000000000002521

https://www.ncbi.nlm.nih.gov/pubmed/31688782 (åpner nytt vindu)

Tromboelastografi for å identifisere blødninger som følge av kirurgi eller koagulopati

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (åpner nytt vindu)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Kilde‎: Acta Anaesthesiol Scand 2010;54(1):111-7.

Arkiv‎: PubMed 19860752

DOI‎: 10.1111/j.1399-6576.2009.02132.x

https://www.ncbi.nlm.nih.gov/pubmed/19860752 (åpner nytt vindu)